Foresite Capital Management III’s Aerie Pharmaceuticals AERI Stock Holding History

Foresite Capital Management III’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-356,492	Closed	-$4.81M	–	9
2020 Q1	$4.81M	Sell	356,492 -1,993,985	-85%	-$37.8M	7.66%	6
2019 Q4	$56.8M	Hold	2,350,477	–	–	31.84%	1
2019 Q3	$45.2M	Buy	2,350,477 +400,000	+21%	+$9.16M	17.25%	1
2019 Q2	$57.6M	Hold	1,950,477	–	–	18.9%	1
2019 Q1	$92.6M	Hold	1,950,477	–	–	24.12%	1
2018 Q4	$70.4M	Buy	1,950,477 +242,431	+14%	+$11.4M	23.13%	1
2018 Q3	$105M	Hold	1,708,046	–	–	23.2%	1
2018 Q2	$115M	Sell	1,708,046 -242,431	-12%	-$13.6M	24.85%	1
2018 Q1	$106M	Hold	1,950,477	–	–	23.06%	1
2017 Q4	$117M	Hold	1,950,477	–	–	32.7%	1
2017 Q3	$94.8M	Hold	1,950,477	–	–	26.11%	1
2017 Q2	$102M	Buy	1,950,477 +353,776	+22%	+$16.5M	33.48%	1
2017 Q1	$72.4M	Sell	1,596,701 -1,751	-0.1%	-$78.1K	27.79%	1
2016 Q4	$60.5M	Sell	1,598,452 -99,432	-6%	-$3.76M	26.29%	1
2016 Q3	$64.1M	Buy	1,697,884 +352,571	+26%	+$7.78M	29.95%	1
2016 Q2	$23.7M	Buy	1,345,313 +388,187	+41%	+$6.28M	16.25%	2
2016 Q1	$11.6M	Buy	957,126 +724,369	+311%	+$11.5M	9.01%	3
2015 Q4	$5.67M	Buy	+232,757	New	+$5.43M	5.03%	8

Other funds holding AERI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Foresite Capital Management III's AERI Position: Q2 2020 in Review

Foresite Capital Management III sold out of Aerie Pharmaceuticals (AERI) in Q2 2020, closing a stake of 356,492 shares — an estimated $4.81M sold.

Foresite Capital Management III first reported a position in AERI in Q4 2015 and held it in 18 quarters. The position peaked at $117M in Q4 2017. 154 funds tracked by Wall St. Rank hold AERI as of Q2 2020.

Foresite Capital Management III reported no remaining Aerie Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Foresite Capital Management III sold 356,492 Aerie Pharmaceuticals shares in Q2 2020, an estimated $4.81M.
Foresite Capital Management III first reported a position in Aerie Pharmaceuticals in Q4 2015 and held it in 18 quarters.
Foresite Capital Management III's Aerie Pharmaceuticals position peaked at $117M in Q4 2017.
154 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2020.

Based on Foresite Capital Management III's 13F filing for Q2 2020, filed 13 Aug 2020.